Skip to main content

Reports, special reports and government responses

View all reports and responses
4th Report - An acceptable risk? The use of Lariam by military personnel
Inquiry Lariam inquiry
HC 567
Report
Response to this report
3rd Special Report - An acceptable risk? The use of Lariam for military personnel: Government Response to the Committee’s Fourth Report of Session 2015–16
HC 648
Special Report
3rd Special Report - An acceptable risk? The use of Lariam for military personnel: Government Response to the Committee’s Fourth Report of Session 2015–16
Inquiry Lariam inquiry
HC 648
Special Report
Letter, 8 September 2015, to Rt Hon Michael Fallon MP, Secretary of State for Defence concerning the use of Lariam by UK Armed Forces
Inquiry Lariam inquiry
Correspondence
Response, 21 September 2015, from the Secretary of State, concerning the use of Lariam in UK Armed Forces
Inquiry Lariam inquiry
Correspondence

Oral evidence transcripts

View all oral evidence transcripts
12 January 2016
Inquiry Lariam inquiry
Witnesses Mark Lancaster TD MP, Parliamentary Under-Secretary of State, Ministry of Defence, Vice Admiral Alasdair Walker OBE, Surgeon General of the Armed Forces, Brigadier Timothy Hodgetts CBE, Medical Director, Defence Medical Services, and Surgeon Captain John Sharpley, Defence Consultant in Psychiatry.
Oral Evidence
8 December 2015
Inquiry Lariam inquiry
Witnesses Dr Ashley Croft, Lieutenant Colonel (Retired) A G Marriott MBE, Trixie Foster, Dr Remington Nevin
Oral Evidence
10 November 2015
Inquiry Lariam inquiry
Witnesses Dr Frances Nichol, Head of Drug Safety and Quality and Mike Kindell, Lead, Established Products, Roche.
Oral Evidence
Mrs Trixie Foster (LAR0028)
Ashley Croft and Remington Nevin (LAR0027)
Mr Lance Cole (LAR0019)

Other publications

No other publications published.

Contact us

  • Email: defcom@parliament.uk
  • Phone: 020 7219 3113/6168 (general enquiries) | 020 7219 2996 (media enquiries)
  • Address: Defence Committee, House of Commons, London SW1A 0AA